arrow
E

Elżbieta Kalicińska

Wroclaw Medical University
H指数:12
被引数:477

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness of pegcetacoplan in individuals with paroxysmal nocturnal haemoglobinuria and suboptimal response to C5 inhibitors

pegcetacoplan在阵发性夜间血红蛋白尿症且对C5抑制剂反应不佳的患者中的真实世界有效性

2026-10-010
PRE
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia

预测的微生物组相关代谢通路与慢性淋巴细胞白血病的免疫检查点调节相关

2026-09-070
OAAI
Corrigendum to “Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study” EClinicalMedicine. 2025 Jul 25:86:103383

勘误:“Obinutuzumab诱导及维持治疗华氏巨球蛋白血症患者的疗效:一项开放标签、单臂II期研究” EClinicalMedicine. 2025年7月25日:86:103383

2026-04-090
OAAI
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中中枢神经系统受累:ERIC(欧洲慢性淋巴细胞白血病研究倡议)国际回顾性研究

2025-10-280
OAAI
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study

奥比妥珠单抗诱导和维持治疗华氏巨球蛋白血症患者的疗效:一项开放标签、单臂2期研究

2025-07-250
OA
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

2024-09-170
OAAI
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

2023-09-2911
OAAI
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病和严重新型冠状病毒肺炎患者的血栓和出血并发症: 欧洲CLL研究计划ERIC的研究

2022-08-268
OAAI
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
2022-07-2716
OA
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

CLL患者的新型冠状病毒肺炎严重程度和死亡率: 国际ERIC和CLL研究的最新进展

LEUKEMIA
IF13.4
2021-11-0169
OAAI
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

内皮激活和应激指数 (EASIX) 可作为血液学和非血液学新型冠状病毒肺炎患者死亡率和总生存率的早期预测指标: 多中心队列研究

2021-09-2417
OAAI
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study
CELLS
IF5.2
2021-05-2322
OAAI